Association of immune cell function assay with protocol biopsy findings and viral infections in well matched kidney transplant recipients

作者：Helanterae I^*; Koskinen P

来源：Clinical Nephrology, 2010, 74(2): 123-131.

• BK virus
• cytomegalovirus
• ImmuKnow (R)
• immune cell function
• assay
• protocol biopsies

Background: Cylex (R) Immune Cell Function Assay (ICFA) is in clinical use, but little is known about its association with screening of viral infections or findings in protocol biopsies. Patients and methods: We analyzed ICFA in our well-matched kidney transplant population. Helsinki University Hospital patients who received a kidney transplant after July 2007 were analyzed. Patients with at least 6 months follow-up and ICFA measured together with the screening for cytomegalovirus (CMV), or polyoma-viruses from urine or plasma, or patients with a protocol biopsy at 6 or 12 months taken at the time of the ICFA were included (n = 27). Immunosuppression was usually implemented with mycophenolate mofetil (MMF), steroids and cyclosporine A(CyA). Biopsies were analyzed with chronic allograft damage index (CADI). Results: Mean immune response in 61 samples was 368 +/- 179 ATP ng/ml. Immune response was lower during BK virus (BKV) or CMV viremia compared to no viremia (p = 0.009 and p = 0.017), and no viremia was seen if immune response was > 380. BK or JC viruria was not associated with low immune response. Immune responses did not differ between patients with high or low CADI scores or between patients with immune activation or no immune activation in biopsies. Immune response in our population was higher than previously reported without increased risk of rejections. ICFA correlated with viremia but not with findings in protocol biopsies. Conclusion: The optimal immune response in our population needs further studies.

• 出版日期2010-8